CHEMBL3644333 [484292]
CHEMBL3644333
| SMILES | CC(=O)N[C@H](CCCNC(=N)N)C(=O)N[C@H]1CCC(=O)NCCC[C@@H](C(=O)O)NC(=O)[C@H](Cc2c[nH]c3ccccc23)NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](Cc2c[nH]cn2)NC1=O |
| InChIKey | SZICVPXPMCPGGO-QNWIHAEASA-N |
| Sequence | None |
| HELM | PEPTIDE1{[ac].[dR].E.H.[dF].R.W.[Orn]}$PEPTIDE1,PEPTIDE1,8:R3-3:R3$$$ |
Chemical Properties
| Hydrogen bond acceptors | 12 |
| Hydrogen bond donors | 17 |
| Rotatable bonds | 18 |
| Log P | -2.366 |
| Molecular weight (Da) | 1067.5 |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
CHEMBL3644333
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0